Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)he xyl]amino }-1-hydroxyethyl)-8-hydroxyquinolin-2(1 H)-one as agonist of the beta2 adrenergic receptor

Details for Australian Patent Application No. 2009331961 (hide)

Owner Almirall, S.A.

Inventors Carrera Carrera, Francesc; Puig Duran, Carlos; Marchueta Hereu, Iolanda; Moyes Valls, Enrique

Agent Davies Collison Cave

Pub. Number AU-A-2009331961

PCT Pub. Number WO2010/072354

Priority 08382082.9 22.12.08 EP

Filing date 15 December 2009

Wipo publication date 1 July 2010

International Classifications

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/072354 Priority application(s): WO2010/072354

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009331976-Multilayer, tube-shaped food film

2009331959-1, 2, 4 -oxadiazole derivatives and their therapeutic use